Viscogliosi Brothers Acquisition in a proxy filing said it will seek shareholder approval for a deadline extension until July 2024.
The SPAC raised $86.25 million in a January 2022 IPO. Since then, the blank-check firm has been focused on businesses that have their primary operations located in North America and Europe in the neuro-musculoskeletal industry. Read more.
